LORENZO COHEN to Liver Neoplasms
This is a "connection" page, showing publications LORENZO COHEN has written about Liver Neoplasms.
Connection Strength
0.218
-
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Sci Transl Med. 2022 04 20; 14(641):eabm6420.
Score: 0.064
-
Randomized, placebo-controlled trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin-induced nausea. Cancer. 2015 Jan 01; 121(1):84-92.
Score: 0.038
-
Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK. Mol Biol Rep. 2012 Feb; 39(2):1683-9.
Score: 0.030
-
Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine. Pancreas. 2011 Jan; 40(1):120-5.
Score: 0.029
-
Na+/K+-ATPase a3 mediates sensitivity of hepatocellular carcinoma cells to bufalin. Oncol Rep. 2011 Mar; 25(3):825-30.
Score: 0.029
-
Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer. 2009 Nov 15; 115(22):5309-18.
Score: 0.027